Decreased Exhaled Nitric Oxide in Mild Persistent Asthma Patients Treated with a Leukotriene Receptor Antagonist, Pranlukast.

Authors:
  • YTYuko Takahashi
    Yuko Takahashi
  • HMHisashi Mitsufuji
    Hisashi Mitsufuji
  • RHRyuji Hataishi
    Ryuji Hataishi
  • TCTailin Cui
    Tailin Cui
  • NTNaohiko Tanaka
    Naohiko Tanaka
  • TKTadashi Kawakami
    Tadashi Kawakami
  • TTTomoyuki Tomita
    Tomoyuki Tomita

Abstract
Exhaled nitric oxide (NO) level decreases after corticosteroid treatment in asthmatics, but the effect of a leukotriene receptor antagonist, pranlukast, on exhaled NO has not been elucidated. Pranlukast treatment in mild persistent asthmatics for 4 weeks decreased the exhaled NO level, which did not differ from the levels in healthy subjects.

This publication has 16 references indexed in Scilit: